Precision Chroma
PrivateLast Round
Accelerator
Jun 10, 2025
Company Overview
Precision Chroma operates in Healthcare & Life Sciences and is based in Christchurch. Its latest recorded funding round was a Seed round in January 2022.
Precision Chroma is a biotechnology company that develops patented 3D printed monolith adsorption (PMA) chromatography columns for the efficient purification of biological therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, 3D Printing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Precision Chroma Comparables
Compare Precision Chroma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lumatix Biotech GmbH | 80% | |
| Sartorius Aktiengesellschaft | 76% | |
| Puridify | 76% |
For institutional investors. Book with your work email.
Precision Chroma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 10, 2025 | ||||
| Early Funding | Aug 1, 2023 | ||||
| Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Precision Chroma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Seed |
| Bridgewest Ventures | Seed |
| BioTools Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2023
$1.5M raised in early funding.
- Jan 1, 2022
Led by Bridgewest Ventures with participation from Callaghan Innovation.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 11, 2026
Precision Chroma receives $13M in Seed financing in New Zealand on Oct 11th '26, in a round led by M Ventures, Merck KGaA’s venture capital arm, to accelerate drug development.
- receives_financingOct 11, 2026
Precision Chroma receives a $7.3M Seed round led by M Ventures, with support from Bridgewest Ventures and participation from Icehouse Ventures and Aspire NZ Seed Fund, to support its commercial launch, scale-up, and progression toward GMP manufacturing applications in New Zealand on Oct 11th '26.
For institutional investors. Book with your work email.
Precision Chroma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Precision Chroma's valuation, stock price, and market status.
Is Precision Chroma a public or private company?
Precision Chroma is a private company.
What is the current stock price of Precision Chroma?
Precision Chroma is a private company, so its shares have no public market price. Caplight tracks Precision Chroma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Precision Chroma worth (valuation)?
Valuation information for Precision Chroma is not publicly available.
Can I buy Precision Chroma stock?
Precision Chroma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Precision Chroma's last funding round?
Precision Chroma's most recent funding round was Accelerator on June 10, 2025.
Who are the main investors in Precision Chroma?
Key investors in Precision Chroma include Bridgewest Ventures.
Will Precision Chroma IPO soon?
No public IPO plans have been announced for Precision Chroma.
How can I track Precision Chroma secondary market activity?
Caplight tracks bids, offers, and trades in Precision Chroma's shares on secondary markets.